"Decoding" informed consent: insights from women regarding breast cancer susceptibility testing.: An article from: The Hastings Center Report

This digital document is an article from The Hastings Center Report, published by Hastings Center on March 1, 1997. The length of the article is 4986 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

From the author: Cancer susceptibility testing is likely to become routine in medical practice, despite many limitations and unanswered questions. These uncertainties greatly complicate the process of informed consent, creating an excellent opportunity to reconsider exactly how it should be conducted. Research with women's reactions to the availability of genetic susceptibility testing for breast cancer dramatically underscores that informed consent ought to be highly individualized, taking care to discern what patients believe about the disease and its causes and what role they want their physician to play.

Citation Details
Title: "Decoding" informed consent: insights from women regarding breast cancer susceptibility testing.
Author: Gail Geller
Publication:The Hastings Center Report (Refereed)
Date: March 1, 1997
Publisher: Hastings Center
Volume: v27 Issue: n2 Page: p28(6)

Distributed by Thomson Gale